NexImmune Competitors and Similar CompaniesClear all
NexImmune's competitors and similar companies include Genprex, Cristal Therapeutics and Dare Bioscience.
 NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. |  Cristal Therapeutics Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases. |  Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 2009 | Founding Date 2011 | Founding Date 2006 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Gaithersburg, US HQ | Locations West Lake Hills, US HQ Austin, US | Locations Maastricht, NL HQ | Locations San Diego, US HQ |
Employees | Employees 5032% decrease | Employees 2865% increase | Employees 4 | Employees 980% increase |
Valuation ($) | Valuation ($) 372.4 k | Valuation ($) 6.3 m | Valuation ($) N/A | Valuation ($) 33.8 m |
Financial | ||||
Net income | Net income ($32.3m) (FY, 2023) | Net income ($16.2m) (FY, 2025) | Net income N/A | Net income ($13.4m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 33.8m | Total funding raised N/A | Total funding raised $ 26.8m | Total funding raised $ 115.7m |
For sources of this data, please see the company profile
View Company Profiles
Genprex
HQ
West Lake Hills, US
Employees
28
Genprex is a gene therapy company developing treatments for cancer and diabetes.
View companyCristal Therapeutics
HQ
Maastricht, NL
Employees
4
Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases.
View companyDare Bioscience
HQ
San Diego, US
Employees
9
Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
View company